3:38 PM ET
8-K
Shareholder Meeting
Oramed Pharmaceuticals Shareholder Meeting
Oramed Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders re-elected six directors and ratified Kesselman & Kesselman as the independent auditor. Stockholders also approved an amendment to the 2019 Stock Incentive Plan to increase the authorized share pool by 3,000,000 shares and voted to hold future say-on-pay votes every three years.